Hagler Mark Arnold bought NBP
July 8, 2026 · Form 4 insider transaction
Hagler Mark Arnold bought 949,050 shares of NovaBridge Biosciences at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
949,050
Price
$0.00
Total value
N/A
InsiderHagler Mark Arnold
RoleOfficer
CompanyNovaBridge Biosciences (NBP)
Security2025 Employee Share Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJuly 8, 2026
Filing dateJuly 10, 2026
Shares owned after949,050
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Number of underlying securities and exercise price expressed in terms of American Depositary Shares ("ADS").; The option vests and becomes exercisable in four equal annual installments beginning on the first anniversary of April 17, 2026.; The Ordinary Shares may be represented by ADSs. Each 10 ADSs represent 23 Ordinary Shares of the Issuer.